MYL : NASDAQ : Health Care
$46.79 | %
Today's Range: 46.11 - 46.94
Avg. Daily Volume: 4,681,200
07/29/16 - 4:00 PM ET

Financial Analysis


MYLAN NV's gross profit margin for the first quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. MYLAN NV has weak liquidity. Currently, the Quick Ratio is 0.98 which shows a lack of ability to cover short-term cash needs. The company's liquidity has increased from the same period last year.

During the same period, stockholders' equity ("net worth") has increased by 13.22% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY16 Q1 FY15
Net Sales ($mil)2191.31871.7
EBITDA ($mil)543.6464.5
EBIT ($mil)246.5289.5
Net Income ($mil)13.956.6


Balance Sheet Q1 FY16 Q1 FY15
Cash & Equiv. ($mil)1306.5408.1
Total Assets ($mil)22644.122123.8
Total Debt ($mil)7474.68461.9
Equity ($mil)10273.49073.3


Profitability Q1 FY16 Q1 FY15
Gross Profit Margin56.4954.78
EBITDA Margin24.824.81
Operating Margin11.2515.47
Sales Turnover0.430.36
Return on Assets3.553.93
Return on Equity7.839.58
Debt Q1 FY16 Q1 FY15
Current Ratio1.671.4
Debt/Capital0.420.48
Interest Expense56.070.3
Interest Coverage4.44.12


Share Data Q1 FY16 Q1 FY15
Shares outstanding (mil)491.36489.49
Div / share0.00.0
EPS0.030.13
Book value / share20.9118.54
Institutional Own % n/a n/a
Avg Daily Volume5011987.05661003.0

Valuation


HOLD. This stock's P/E ratio indicates a significant discount compared to an average of 45.39 for the Pharmaceuticals industry and a premium compared to the S&P 500 average of 25.05. To use another comparison, its price-to-book ratio of 2.24 indicates a discount versus the S&P 500 average of 2.81 and a significant discount versus the industry average of 8.86. The price-to-sales ratio is above the S&P 500 average, but well below the industry average. Upon assessment of these and other key valuation criteria, MYLAN NV proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
MYL 30.04 Peers 45.39   MYL 12.62 Peers 31.23

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

MYL is trading at a significant discount to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

MYL is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
MYL 8.01 Peers 16.56   MYL 0.16 Peers 0.58

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

MYL is trading at a significant discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

MYL trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
MYL 2.24 Peers 8.86   MYL -28.45 Peers -19.27

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

MYL is trading at a significant discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, MYL is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
MYL 2.36 Peers 23.05   MYL 23.78 Peers 6.33

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

MYL is trading at a significant discount to its industry on this measurement.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

MYL has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades